Clinical Trials Browser

Phase 4 × OTHER_GOV × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Clear all

NCT05137860 2022-01-18

Efficacy of the Use of Bortezomib for the Treatment of Relapsed Leukemia or Positive MRD

Phase 4 Unknown

LymphoidOther hematologic neoplasm

Recurrence, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05133310 2022-01-04

Effect of Simvastatin on Sepsis and Febrile Neutropenia in Patients With Acute Lymphoblastic Leukemia

Phase 4 Unknown

Classical hematologyLymphoidOther hematologic neoplasm

Sprains and Strains, Sepsis, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Febrile Neutropenia